Natasha M Nesbitt, PhD

Natasha M Nesbitt, PhD has a diverse work experience in the scientific field. Natasha M is currently serving as the Chief Scientific Officer at Blood Cell Technologies, LLC, where they focus on identifying and validating novel cellular and diagnostic technologies for human blood disorders. In this role, they secured over $2.2 million in non-dilutive grant funding to establish a drug discovery program.

Natasha has also worked as a Lead Writer at Grant Engine, where they collaborated with CEOs, CSOs, and VPs to create research proposals that appealed to reviewers with different levels of expertise.

Natasha M has a strong research background, highlighted by their role as a Research and Development Scientist in Hematology at The Department of Medicine at Stony Brook University. Natasha M collaborated with a multidisciplinary team to identify and validate a novel drug target for enhancing platelet production, resulting in several publications in peer-reviewed journals. Their expertise in the field was recognized when they were invited to serve as a Forum-Editor for the journal Antioxidants & Redox Signaling.

Natasha has also served as a Forum Co-Editor at Antioxidants and Redox Signaling and as a Research Scientist at the Institute of Chemical Biology and Drug Discovery. In these roles, they demonstrated their knowledge in drug discovery and successfully facilitated communication between researchers.

Natasha M gained valuable experience as a Postdoctoral Associate and Fellow at Stony Brook University, where they worked on projects related to chemical biology and identifying infectious disease drug targets. Natasha M established cross-functional collaborations and published multiple articles in peer-reviewed journals. Natasha M was also recognized for their contributions through invitations to present posters at scientific conferences and write a preview for a scientific journal article.

Earlier in their career, Natasha worked as a Graduate Student/Assistant/Fellow at The Pennsylvania State University, where they completed their PhD in Biochemistry, Microbiology, and Molecular Biology. Their research focused on protein chemistry and enzymology, specifically studying the production of the cofactor lipoic acid. Natasha M published several articles and received prestigious fellowships and a scholarship for their work.

Additionally, Natasha gained early research experience as a Research Associate Intern at PARKE-DAVIS, where they conducted experiments related to apoptosis and drug discovery.

Overall, Natasha M Nesbitt, PhD has a strong background in scientific research, drug discovery, and collaboration in academia and industry settings.

Dr. Natasha M Nesbitt has an extensive and diverse education history. Natasha M obtained a Certificate of Completion in Fundamentals of the Bioscience Industry from Stony Brook University in 2019, with a focus on the bioscience industry through the Center for Biotechnology. Prior to that, they pursued their postdoctoral studies in Chemical Biology at Stony Brook University from 2005 to 2012. Dr. Nesbitt earned their Ph.D. in Biochemistry and Molecular Biology from Penn State University between 1999 and 2005. Their undergraduate education took place at Michigan State University, where they completed their Bachelor of Science degree in Biochemistry from 1994 to 1998.

In addition to their formal education, Dr. Nesbitt has obtained several certifications. In 2019, they completed the "Introduction to Molecular Modeling in Drug Discovery" program offered by Schrödinger. Furthermore, in 2020, they obtained a certification in "USRx: Prescription Drug Regulation, Cost, and Access: Current Controversies in Context" from HarvardX, an online learning initiative by Harvard University through edX.